On December 9, 2025, DAY BY DAY reiterated a Sell recommendation for Siemens Healthineers (OTCPK:SEMHF). As of December 6, the average one-year price target for the company stands at $65.88 per share, indicating a potential upside of 13.59% from its latest closing price of $58.00 per share.
The projected annual revenue for Siemens Healthineers is $23.83 billion, reflecting a 1.95% increase. Institutional ownership has decreased by 11.14% over the last three months to 40.4 million shares, with 281 funds reporting positions, down by 5.70% from the previous quarter.
